Amicus Therapeutics, Inc. (FOLD) Tops Q4 EPS by 12c

Amicus Therapeutics, Inc. (NASDAQ: FOLD) reported Q4 EPS of ($0.25), $0.12 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $922 thousand, versus the consensus estimate of $6.06 million.

For earnings history and earnings-related data on Amicus Therapeutics, Inc. (FOLD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank